BSE filing, NSE: THOMASCOOK. Summary written from the filing by ALFA Finder's alert engine.
Thomas Cook (India) Ltd: key numbers
- Share price
- ₹95.01
- Market cap
- ₹4,470 Cr
- Revenue (annual)
- ₹8,398 Cr
- Net profit (annual)
- ₹218.8 Cr
- P/E (TTM)
- 21.9×Sector 34.1×
- Promoter holding
- 64.77%+0.00% QoQ
- FII holding
- 5.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thomas Cook (India) Ltd
All →Thomas Cook (India) Capacity Expansion
Thomas Cook India has launched its first travel outlet in Gorakhpur, Uttar Pradesh. This expansion increases the company's network to 12 locations across the state.
- new outlets
- 1.0 outlet
Thomas Cook (India) Earnings Call Transcript: Key Takeaways
Q2 FY27 income fell 5% to ₹2,003 Cr; PBT flat at ₹84.8 Cr on cost agility. Financial Services and Sterling offset weak international travel.
Thomas Cook (India) Investor Presentation: Key Takeaways
Q2 FY27 revenue from operations ₹19,442mn (-6% YoY), PBT before exceptionals ₹848mn (+1%), PAT ₹536mn (-24%). Financial Services and Leisure grew; Travel and DEI fell. Sterling demerger in progress.
Thomas Cook (India) Results Update
Thomas Cook (India) reported Q2 FY27 PBT of Rs 848 Mn, flat year-on-year. Financial Services revenue rose 21%, while India leisure forward bookings are up 30%.
Thomas Cook (India) Q2 FY27 Results: Net Profit ₹53.7 Cr, Down 24.2% YoY
Thomas Cook (India) Ltd reported revenue from operations of ₹1,944 Cr (-6.2% YoY) and net profit of ₹53.7 Cr (-24.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹53.7 Cr · -24.2% YoY
Thomas Cook (India) Business Update
Thomas Cook India and SOTC Travel launched a year-end holiday portfolio spanning multiple destinations worldwide. The marketing release highlights curated group tours and customised New Year experiences.
Other merger & restructuring announcements
All →Fermenta Biotech Merger & Restructuring
Fermenta Biotech Limited's board has approved the closure of its inactive wholly-owned subsidiary, Fermenta Biotech (UK) Limited. The move aims to reorganize corporate structure and reduce compliance costs following the UK's exit from the EU.
Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr